SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)
Clinical trials for SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) explained in plain language.
Never miss a new study
Get alerted when new SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) trials appear
Sign up with your email to follow new studies for SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a diabetes drug shield kidneys in sickle cell disease?
Disease control Not yet recruitingThis study tests whether empagliflozin, a drug already approved for kidney disease, can slow kidney damage in people with sickle cell anemia. About 20 adults with sickle cell disease and early signs of kidney trouble will take the drug for several months. Researchers will measure…
Matched conditions: SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New blood processing method could mean fewer transfusions for sickle cell patients
Disease control Not yet recruitingThis study tests whether red blood cells processed with the Hemanext ONE® system (hypoxic RBCs) last longer in the body compared to standard blood transfusions for people with sickle cell anemia. About 48 participants aged 7 and older who need regular transfusions will receive bo…
Matched conditions: SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)
Phase: NA • Sponsor: Hemanext • Aim: Disease control
Last updated May 07, 2026 18:39 UTC